Published in
Cell Press, Cell Reports, 3(36), p. 109415, 2021
DOI: 10.1016/j.celrep.2021.109415
Links
Tools
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Journal article published in 2021 by
Markus Hoffmann 
,
Heike Hofmann-Winkler,
Nadine Krüger,
Amy Kempf,
Inga Nehlmeier,
Luise Graichen,
Prerna Arora ,
Anzhalika Sidarovich ,
Anna-Sophie Moldenhauer,
Martin S. Winkler,
Sebastian Schulz ,
Hans-Martin Jäck,
Metodi V. Stankov,
Georg M. N. Behrens ,
Stefan Pöhlmann
,
Heike Hofmann-Winkler,
Nadine Krüger,
Amy Kempf,
Inga Nehlmeier,
Luise Graichen,
Prerna Arora ,
Anzhalika Sidarovich ,
Anna-Sophie Moldenhauer,
Martin S. Winkler,
Sebastian Schulz ,
Hans-Martin Jäck,
Metodi V. Stankov,
Georg M. N. Behrens ,
Stefan Pöhlmann
This paper is made freely available by the publisher.
Full text: Download
Data provided by 